The search found 4102 results.
Video
Yale New Haven Health is using Imprivata OneSign to identify users who may have been exposed to patients with infectious diseases — and therefore represent a potential risk of spreading the disease.
For more information, visit www.imprivata.com/covid-19
Press
Healthcare Executives, Industry Experts and Thought Leaders Address Healthcare IT Challenges, Trends and Priorities for Improving Clinician Workflow and Securing Patient Data
Video
Most organizations who are enabled for electronic prescribing of controlled substances (EPCS) use the institutional identity proofing model.
For more information, visit www.imprivata.com/covid-19
Video
Children’s Hospital of the King’s Daughters (like many other customers) is experiencing an increase in remote workers during this crisis.
For more information, visit www.imprivata.com/covid-19
Press
User Productivity, Data Security and Government Compliance Drive Imprivata OneSign Adoption in the Middle East
Video
Many organizations are needing to shift care providers from their specialties in order to support testing and care of patients with COVID-19.
For more information, visit www.imprivata.com/covid-19
Video
Like many organizations, Virtua Health is experiencing a swift ramp up in remote workforce, including for telehealth and administrative workers.
For more information, visit www.imprivata.com/covid-19
Press
Proven Enterprise Software and Security Industry Executive Brings Extensive Strategic Marketing and Product Management Experience to Accelerate Company's Global Growth
Video
Many organizations are increasing their remote workforce — one hospital system in Australia, for example, has about 25% of their employees suddenly being asked to work from home.
For more information, visit www.imprivata.com/covid-19
Video
Nurses at Cambridge Health Alliance (CHA) use tablets to share patient vitals with remote physicians, and, especially now, need a quick, easy, and near touch-free login experience.
For more information, visit www.imprivata.com/covid-19